Wimbledon Girls Finalist Nikola Bartunkova Suspended for Doping
Wimbledon Girls Finalist Nikola Bartunkova Provisionally Suspended for Doping
Nikola Bartunkova, the 18-year-old Czech tennis player who reached the Wimbledon girls’ singles final last year, has been provisionally suspended by the International Tennis Integrity Agency (ITIA) for doping.
The ITIA announced on Thursday that Bartunkova tested positive for trimetazidine, a banned heart medication, at tournaments in Trnava, Slovakia, and Maribor, Slovenia, in February and March, respectively. Trimetazidine, also known as TMZ, is a medication used to treat angina, a condition that causes chest pain. It is banned in sports because it can enhance endurance and performance.
Bartunkova’s positive tests are the latest in a series of high-profile cases involving TMZ. In 2021, Russian figure skater Kamila Valieva tested positive for the medication at the Beijing Winter Olympics, sparking a major controversy. Additionally, 23 Chinese swimmers were found to have used TMZ while preparing for the Tokyo Olympics.
Bartunkova, who is currently ranked 282nd in the world, has been banned from all sanctioned tennis events pending an ITIA hearing. She reached the singles semifinals and the doubles final at the 2022 Junior Roland Garros, and was considered one of the rising stars in women’s tennis.
The ITIA’s investigation into Bartunkova’s case is ongoing, and it is unclear at this time what penalties she may face if found guilty of doping. The agency has a zero-tolerance policy for doping and has been cracking down on the use of performance-enhancing substances in tennis.
The news of Bartunkova’s suspension is a blow to the sport of tennis and raises concerns about the prevalence of doping among young athletes. It is important for all athletes to compete fairly and ethically, and the ITIA’s efforts to combat doping are essential to maintaining the integrity of the sport.